Bioadaptives, Inc. (BDPT) Change in Cash (2013 - 2026)

Bioadaptives has reported Change in Cash for 13 years, with the latest figure at -$84839.0 in Q1 2026.

• Quarterly Change in Cash rose 13.35% year-over-year to -$84839.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34042.0 (up 70.47% YoY) and the FY2025 annual result came in at $20975.0, down 72.65% from the prior year.
• Change in Cash fell to -$84839.0 in Q1 2026 per BDPT's latest filing, from $99172.0 in the prior quarter.
• Over five years, Change in Cash peaked at $171018.0 in Q2 2025 and troughed at -$151309.0 in Q3 2025.
• A 5-year average of -$548.82 and a median of -$19360.0 in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash plunged 1654.5% in 2023, then jumped 983.36% in 2025.
• Over 5 years, Change in Cash stood at $5873.0 in 2022, then slumped by 1654.5% to -$91296.0 in 2023, then surged by 202.5% to $93577.0 in 2024, then increased by 5.98% to $99172.0 in 2025, then sank by 185.55% to -$84839.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$84839.0, $99172.0, and -$151309.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.